Company

Scienture

As of the edition of 20 October 2026, Scienture runs 2 drugs, 2 of them marketed.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Marketed2
Total2

Marketed drugs and when their US protection ends

DrugUS protectionRoute B rows
Losartannone listed1
Naloxonenone listed10

A route B row is one company at one target.